helixstreet is building a Swiss Reference Genome with SMRT Long Read Sequencing Technology.

https://www.startupticker.ch/en/news/october-2019/nvidia-supports-helixstreet-in-developing-its-ai-based-dna-platform

helixstreet is proud to be part of NVIDIA’s inception program for promising AI startups.

https://assets.publishing.service.gov.uk/media/5d820ef740f0b61c7cd70013/IlluminaPacbio_Summary_of_customer_calls.pdf

Competiton & Markets Authority published a new report regarding the Merger of ILMN & PACB – the reports removes in my humble opinion the existing obstacles of the CMA.

https://www.crunchbase.com/hub/switzerland-health-care-companies#section-leaderboard

helixstreet @ https://www.dayone.swiss/dayone/conference.html

helixstreet is proud to be elected as one of the DayOne Conference startups to present at the Conference.

helixstreet is now mentioned in the crunchbase database: https://www.crunchbase.com/organization/helixstreet-com#section-overview

helixstreet app allows you to store your DNA in several electronic patient dossiers. For example Swiss customers will be able to store their sequencing data in their Electronic Dossier.